Skip to main content
Erschienen in: European Journal of Plastic Surgery 3/2020

01.06.2020 | Original Paper

A review of the reconstructive methods in the management of axillary hidradenitis suppurativa

verfasst von: Jia Yuan Lee, Siew Cheng Chai, Mohammad Ali Mat Zain, Normala Basiron

Erschienen in: European Journal of Plastic Surgery | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Hidradenitis suppurativa (HS) is a chronic debilitating inflammatory disease of the apocrine gland-bearing body areas, characterized by painful recurrent abscess, sinus tract formation, and scarring. The treatment for HS consists of medical and surgical treatments in a multidisciplinary approach. Wide excision and reconstruction over the axillary hidradenitis suppurativa can be challenging due to possible morbidities; for example, scarring can lead to contracture over the axilla.

Methods

In this report, we present 10 patients who underwent wide excision and reconstruction for the axilla hidradenitis suppurativa in our center from the year 2007 until the year 2017 with a mean follow-up of 3.17 years. All relevant operative information and data were collected from past medical records.

Results

Seventeen sites of affected axilla were reconstructed post-wide excision using various methods; from primary closure (n = 5), split thickness skin grafting (n = 5), and local fasciocutaneous flap (n = 2) to pedicle partial latissimus dorsi myocutaneous flap (n = 5). Primary closure is only achievable in smaller axillary defects with mean size of 65.2 cm2. Larger defects with averages 2 to 3 times the size are not amenable for primary closure and require skin grafting or flap coverage. Complications include wound dehiscence (n = 1), poor graft take (n = 3), and marginal flap edge necrosis (n = 1). Local fasciocutaneous flap is versatile and easily designed with the shortest mean operative time of 95 min. Hospital stay is shorter for primary closure and local fasciocutaneous flap with an average of 6 days for each as compared to using skin grafting (20 days) and pedicle partial latissimus dorsi myocutaneous flap (9 days). Only one recurrence (5.8%) was noted in a patient with primary closure post excision. All patients are satisfied with the surgical outcome and have no restriction of movement over their shoulders. Esthetically, reconstruction using primary closure and flap coverage methods is superior to skin grafting.

Conclusions

Axillary HS requires complete excision to prevent future recurrence. Reconstructive method with soft tissue coverage presented a better outcome compared to split thickness skin grafting in terms of surgical time, recovery rate, morbidity, as well as functional and esthetic outcomes.
Level of evidence: Level IV, therapeutic study.
Literatur
1.
Zurück zum Zitat Romanowski KS, Fagin A, Werling B, Kass G, Liao J, Granchi T, Kealey GP, Wibbenmeyer L (2017) Surgical management of hidradenitis suppurativa. J Burn Care Res 38(6):365–370PubMed Romanowski KS, Fagin A, Werling B, Kass G, Liao J, Granchi T, Kealey GP, Wibbenmeyer L (2017) Surgical management of hidradenitis suppurativa. J Burn Care Res 38(6):365–370PubMed
2.
Zurück zum Zitat Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35(2):191–194PubMed Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 35(2):191–194PubMed
3.
Zurück zum Zitat Dufour DN, Emtestam L, Jemec GB (2014) Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J 90(1062):216–221PubMedPubMedCentral Dufour DN, Emtestam L, Jemec GB (2014) Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J 90(1062):216–221PubMedPubMedCentral
4.
Zurück zum Zitat Prens E, Deckers I (2015) Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 73(5):S8–S11PubMed Prens E, Deckers I (2015) Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol 73(5):S8–S11PubMed
5.
Zurück zum Zitat Slade DEM, Powell BW, Mortimer PS (2003) Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56(5):451–461PubMed Slade DEM, Powell BW, Mortimer PS (2003) Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 56(5):451–461PubMed
6.
Zurück zum Zitat Kouris A, Platsidaki E, Christodoulou C et al (2017) Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology 232(6):687–691 Kouris A, Platsidaki E, Christodoulou C et al (2017) Quality of life and psychosocial implications in patients with hidradenitis suppurativa. Dermatology 232(6):687–691
7.
Zurück zum Zitat Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen K (2018) Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish Nationwide registry study. J Invest Dermatol 138(1):46–51PubMed Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen K (2018) Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish Nationwide registry study. J Invest Dermatol 138(1):46–51PubMed
8.
Zurück zum Zitat Falola RA, DeFazio MV, Anghel EL et al (2016) What heals hidradenitis suppurativa: surgery, immunosuppression, or both? Plast Reconstr Surg 138(3):219S–229SPubMed Falola RA, DeFazio MV, Anghel EL et al (2016) What heals hidradenitis suppurativa: surgery, immunosuppression, or both? Plast Reconstr Surg 138(3):219S–229SPubMed
9.
Zurück zum Zitat Mehdizadeh A, Hazen PG, Bechara FG et al (2015) Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol 73(5):S70–S77PubMed Mehdizadeh A, Hazen PG, Bechara FG et al (2015) Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis. J Am Acad Dermatol 73(5):S70–S77PubMed
10.
Zurück zum Zitat Banerjee AK (1992) Surgical treatment of hidradenitis suppurativa. Br J Surg 79:863–866PubMed Banerjee AK (1992) Surgical treatment of hidradenitis suppurativa. Br J Surg 79:863–866PubMed
11.
Zurück zum Zitat Parks RW, Parks TG (1997) Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 79(2):83–89PubMedPubMedCentral Parks RW, Parks TG (1997) Pathogenesis, clinical features and management of hidradenitis suppurativa. Ann R Coll Surg Engl 79(2):83–89PubMedPubMedCentral
12.
Zurück zum Zitat Rompel R, Petres J (2000) Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatologic Surg 26(7):638–643 Rompel R, Petres J (2000) Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatologic Surg 26(7):638–643
13.
Zurück zum Zitat Humphries LS, Kueberuwa E, Beederman M et al (2016) Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J Plast Reconstr Aesthetic Surg 69(4):554–566 Humphries LS, Kueberuwa E, Beederman M et al (2016) Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: a single-center experience. J Plast Reconstr Aesthetic Surg 69(4):554–566
14.
Zurück zum Zitat Pearce FB (2014) Richardson KA (2014) cost comparison of split thickness skin grafting with and without bilayer dermal regenerative templates for bilateral axillary hidradenitis suppurativa: a retrospective comparison study. Wound Med 7:18–23 Pearce FB (2014) Richardson KA (2014) cost comparison of split thickness skin grafting with and without bilayer dermal regenerative templates for bilateral axillary hidradenitis suppurativa: a retrospective comparison study. Wound Med 7:18–23
15.
Zurück zum Zitat Gonzaga TA, Endorf FW, Mohr WJ, Ahrenholz DH (2013) Novel surgical approach for axillary hidradenitis suppurativa using a bilayer dermal regeneration template: a retrospective case study. J Burn Care Res 34(1):51–57PubMed Gonzaga TA, Endorf FW, Mohr WJ, Ahrenholz DH (2013) Novel surgical approach for axillary hidradenitis suppurativa using a bilayer dermal regeneration template: a retrospective case study. J Burn Care Res 34(1):51–57PubMed
16.
Zurück zum Zitat Elwood ET, Bolitho DG (2001) Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg 46(1):49–51PubMed Elwood ET, Bolitho DG (2001) Negative-pressure dressings in the treatment of hidradenitis suppurativa. Ann Plast Surg 46(1):49–51PubMed
17.
Zurück zum Zitat Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO (2000) Chronic axillary hidradenitis - the efficacy of wide excision and flap coverage. Br J Plast Surg 53(5):434–436PubMed Soldin MG, Tulley P, Kaplan H, Hudson DA, Grobbelaar AO (2000) Chronic axillary hidradenitis - the efficacy of wide excision and flap coverage. Br J Plast Surg 53(5):434–436PubMed
18.
Zurück zum Zitat Hudson D, Krige J (1993) Axillary hidradenitis suppurativa: wide excision and flap coverage is best. Eur J Plast Surg 16:94–97 Hudson D, Krige J (1993) Axillary hidradenitis suppurativa: wide excision and flap coverage is best. Eur J Plast Surg 16:94–97
19.
Zurück zum Zitat Laredo Ortiz C, López Castillo V, Solesio Pilarte F et al (2010) Experience using the thoracodorsal artery perforator flap in axillary hidradenitis suppurativa cases. Aesthet Plast Surg 34(6):785–792 Laredo Ortiz C, López Castillo V, Solesio Pilarte F et al (2010) Experience using the thoracodorsal artery perforator flap in axillary hidradenitis suppurativa cases. Aesthet Plast Surg 34(6):785–792
20.
Zurück zum Zitat Hallock GG (2013) Island thoracodorsal artery perforator-based V-Y advancement flap after radical excision of axillary hidradenitis. Ann Plast Surg 71(4):390–393PubMed Hallock GG (2013) Island thoracodorsal artery perforator-based V-Y advancement flap after radical excision of axillary hidradenitis. Ann Plast Surg 71(4):390–393PubMed
21.
Zurück zum Zitat Marchesi A, Marcelli S, Zingaretti N (2018) Pedicled thoracodorsal artery perforator and muscle-sparing latissimus dorsi flaps in the axillary reconstruction after hidradenitis suppurativa excision. Ann Plast Surg 81(6):694–701PubMed Marchesi A, Marcelli S, Zingaretti N (2018) Pedicled thoracodorsal artery perforator and muscle-sparing latissimus dorsi flaps in the axillary reconstruction after hidradenitis suppurativa excision. Ann Plast Surg 81(6):694–701PubMed
22.
Zurück zum Zitat Rehman N, Kannan RY, Hassan S, Hart NB (2005) Thoracodorsal artery perforator (TAP) type I V-Y advancement flap in axillary hidradenitis suppurativa. Br J Plast Surg 58(4):441–444PubMed Rehman N, Kannan RY, Hassan S, Hart NB (2005) Thoracodorsal artery perforator (TAP) type I V-Y advancement flap in axillary hidradenitis suppurativa. Br J Plast Surg 58(4):441–444PubMed
23.
Zurück zum Zitat Hamdi M, Van Landuyt K, Hijjawi JB (2008) Surgical technique in pedicled thoracodorsal artery perforator flaps: a clinical experience with 99 patients. Plast Reconstr Surg 121(5):1632–1641PubMed Hamdi M, Van Landuyt K, Hijjawi JB (2008) Surgical technique in pedicled thoracodorsal artery perforator flaps: a clinical experience with 99 patients. Plast Reconstr Surg 121(5):1632–1641PubMed
24.
Zurück zum Zitat Lipshutz H (1974) Closure of axillary hidradenitis defect with local triangular flaps. Plast Reconstr Surg 53(6):677–679PubMed Lipshutz H (1974) Closure of axillary hidradenitis defect with local triangular flaps. Plast Reconstr Surg 53(6):677–679PubMed
25.
Zurück zum Zitat O’Brien J, Wysocki J, Anastasi G (1976) Limberg flap coverage for axillary defects resulting from excision of hidradenitis suppurativa. Plast Reconstr Surg 58(3):358–358 O’Brien J, Wysocki J, Anastasi G (1976) Limberg flap coverage for axillary defects resulting from excision of hidradenitis suppurativa. Plast Reconstr Surg 58(3):358–358
26.
Zurück zum Zitat Hermanson A (1982) Surgical treatment of axillary hidradenitis suppurativa. Scand J Plast Reconstr Surg 16(2):163–165PubMed Hermanson A (1982) Surgical treatment of axillary hidradenitis suppurativa. Scand J Plast Reconstr Surg 16(2):163–165PubMed
27.
Zurück zum Zitat Altmann S, Fansa H, Schneider W (2004) Axillary hidradenitis suppurativa: a further option for surgical treatment. J Cutan Med Surg 8(1):6–10PubMed Altmann S, Fansa H, Schneider W (2004) Axillary hidradenitis suppurativa: a further option for surgical treatment. J Cutan Med Surg 8(1):6–10PubMed
28.
Zurück zum Zitat Ching DL, Mughal M, Papas A, Soldin M (2017) Axillary reconstruction for hidradenitis suppurativa with an inner-arm transposition flap creating a brachioplasty effect. Arch Plast Surg 44(3):228–232PubMedPubMedCentral Ching DL, Mughal M, Papas A, Soldin M (2017) Axillary reconstruction for hidradenitis suppurativa with an inner-arm transposition flap creating a brachioplasty effect. Arch Plast Surg 44(3):228–232PubMedPubMedCentral
29.
Zurück zum Zitat Sharma R, Kapoor K, Singh G (2006) Reconstruction in extensive axillary hidradenitis suppurativa with local fasciocutaneous V-Y advancement flaps. Indian J Plast Surg 39(1):18 Sharma R, Kapoor K, Singh G (2006) Reconstruction in extensive axillary hidradenitis suppurativa with local fasciocutaneous V-Y advancement flaps. Indian J Plast Surg 39(1):18
Metadaten
Titel
A review of the reconstructive methods in the management of axillary hidradenitis suppurativa
verfasst von
Jia Yuan Lee
Siew Cheng Chai
Mohammad Ali Mat Zain
Normala Basiron
Publikationsdatum
01.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Plastic Surgery / Ausgabe 3/2020
Print ISSN: 0930-343X
Elektronische ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-019-01608-9

Weitere Artikel der Ausgabe 3/2020

European Journal of Plastic Surgery 3/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.